Infection Surveillance Solutions Market By Product (Services and Software), By Type (Urinary Tract Infection, Surgical Site Infection, Blood Stream Infection and Others), By End-Use (Hospitals, Long Term Care Centers and Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

The infection surveillance solutions market is set to reach US$ 934.7 Mn in 2026 from US$ 330.7 Mn in 2017 projecting excellent growth at a CAGR of 12.4% from 2018 to 2026. As per the latest research citing provided by World Health Organization (WHO), in the near future glooming threat of hospital acquired infection and rampant growth in antibiotic resistance by microbes will result in increased mortality worldwide. There is need to monitor and supervise infectious disease in real time mode.

Market Synopsis 

Get a sample copy for more information

"Provision of real time surveillance and rampant growth in the IT-healthcare industry drive the software market growth"

Software solutions are leading the product segment for infection surveillance solutions market. The major parameters that influence its growth are its ability to provide real time surveillance of infectious disease and rampant growth in IT-healthcare industry. Web based solutions are gaining immense popularity owing to availability in different configurations and immediate return on initial investment. On-premise software solutions are feasible in hospitals owing to low maintenance cost incurred and low subscription fee. Services segment will growth at a steady pace during the forecast period owing to entry of large number of market participants willing to provide outsourcing solutions related to infection surveillance. 

Get a sample copy for more information

"Prolonged use of catheters and increasing number of patients with suppressed immune system drive the urinary tract infection market growth"

Urinary tract infection are reigning the type segment for infection surveillance solutions market. Increasing number of patients suffering with suppressed immune system and prolonged use of catheters drive the market growth for urinary tract infection. It is more susceptible in the women population in comparison to men. Others segment comprises of infections caused by pneumonia causing microbes and methicillin resistant staphylococcus aureus bacteria. They will register growth at a rapid pace on account of significant rise in hospital acquired infections worldwide. 

"Increasing number of inbound patients and significant rise in the number of surgeries performed drive the hospitals market growth"

In the present scenario hospitals are dominating the end-use segment for infection surveillance solutions market. The key factors that determine its outstanding growth are increasing number of inbound patients and rise in the number of surgeries performed. Lon term care centers will witness fast growth during the forecast period from 2018 to 2026, owing to its ability to antimicrobial resistance infection and increasing outbound patients due to low healthcare cost incurred. 

Get a sample copy for more information

"Rising prevalence of hospital acquired infection (HAI) and existence of excellent healthcare framework drive the market growth in North America"

Currently North America holds 35% share in the regional segment for global infection surveillance solutions market. The important parameters that are responsible for the excellent market growth in North America are existence of excellent healthcare framework and rising prevalence of hospital acquired infection. Presence of pioneering IT-healthcare companies specializing in providing infection surveillance solutions such as Truven Health Analytics, Becton Dickinson & Company and Baxter International, Inc. etc. further consolidate the market growth in North America. Europe is the second largest regional market accounting for 30% share owing to proactive government policy in fighting infectious disease and enhanced funding in the research and development segment to counteract microbial resistance issue. Asia Pacific represents 20% market share and will be registering steady growth on account of presence of large patient pool suffering with hospital acquired infection and rising public health awareness regarding infectious disease.

Historical & Forecast Period

This research report presents the analysis of each segment from 2016 to 2026 considering 2017 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segments are calculated for the forecast period from 2018 to 2026. 

Report Scope by Segments

Infection surveillance solutions market segmentation is as follows:

IT-healthcare companies pioneering in providing infection surveillance solutions are Becton Dickinson and Company, Deb Group, Ltd., Gojo Industries, Inc., Baxter International, Inc., Truven Health Analytics, Hygreen, Inc., Premier, Inc., Atlas Medical Software, RL Solutions and Wolters Kluwer N.V.

Key questions answered in this report

• Which are the major IT-healthcare companies providing infection surveillance solutions?
• What is the global mortality rate associated with hospital acquired infection and antibiotic resistance by bacteria?
• What is the role of software solution in monitoring infectious disease?
• What is the disease etiology associated with urinary tract infection?
• What is the healthcare burden incurred by hospitals related to infectious disease?
• Why is North America the leading regional segment in infection surveillance solutions market?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global ISS Market Portraiture
2.2. Global ISS Market, by Product, 2017 (US$ Mn)
2.3. Global ISS Market, by Type, 2017 (US$ Mn)
2.4. Global ISS Market, by End-Use, 2017 (US$ Mn)
2.5. Global ISS Market, by Geography, 2017 (US$ Mn)

Chapter 3. Infection Surveillance Solutions (ISS) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global ISS Market, by Key Players, 2017

Chapter 4. Global Infection Surveillance Solutions (ISS) Market, by Product
4.1. Overview
4.2. Services
4.3. Software

Chapter 5. Global Infection Surveillance Solutions (ISS) Market, by Type
5.1. Urinary Tract Infection
5.2. Surgical Site Infection
5.3. Blood Stream Infection
5.4. Others

Chapter 6. Global Infection Surveillance Solutions (ISS) Market, by End-Use
6.1. Overview
6.2. Hospitals
6.3. Long Term Care Centers
6.4. Others

Chapter 7. Global Infection Surveillance Solutions (ISS) Market, by Geography
7.1. Overview
7.2. North America ISS Market Analysis, 2016 – 2026
7.2.1. North America ISS Market, by Product, 2016 – 2026 (US$ Mn)
7.2.2. North America ISS Market, by Type, 2016 – 2026 (US$ Mn)
7.2.3. North America ISS Market, by End-Use, 2016 – 2026 (US$ Mn)
7.2.4. North America ISS Market, by Country, 2016 – 2026 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe ISS Market Analysis, 2016 – 2026
7.3.1. Europe ISS Market, by Product, 2016 – 2026 (US$ Mn)
7.3.2. Europe ISS Market, by Type, 2016 – 2026 (US$ Mn)
7.3.3. Europe ISS Market, by End-Use, 2016 – 2026 (US$ Mn)
7.3.4. Europe ISS Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific ISS Market Analysis, 2016 – 2026
7.4.1. Asia Pacific ISS Market, by Product, 2016 – 2026 (US$ Mn)
7.4.2. Asia Pacific ISS Market, by Type, 2016 – 2026 (US$ Mn)
7.4.3. Asia Pacific ISS Market, by End-Use, 2016 – 2026 (US$ Mn)
7.4.4. Asia Pacific ISS Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.4.4.1. China
7.4.4.2. Japan
7.4.4.3. Rest of Asia Pacific
7.5. Latin America ISS Market Analysis, 2016 – 2026
7.5.1. Latin America ISS Market, by Product, 2016 – 2026 (US$ Mn)
7.5.2. Latin America ISS Market, by Type, 2016 – 2026 (US$ Mn)
7.5.3. Latin America ISS Market, by End-Use, 2016 – 2026 (US$ Mn)
7.5.4. Latin America ISS Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East and Africa ISS Market Analysis, 2016 – 2026
7.6.1. MEA ISS Market, by Product, 2016 – 2026 (US$ Mn)
7.6.2. MEA ISS Market, by Type, 2016 – 2026 (US$ Mn)
7.6.3. MEA ISS Market, by End-Use, 2016 – 2026 (US$ Mn)
7.6.4. MEA ISS Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Atlas Medical Software
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. News Coverage
8.2. Becton Dickinson and Company
8.3. Baxter International, Inc.
8.4. Deb Group Ltd.
8.5. Gojo Industries, Inc.
8.6. Hygreen, Inc.
8.7. Premier, Inc.
8.8. RL Solutions
8.9. Truven Health Analytics
8.10. Wolters Kluwer N.V.

* ISS - Infection Surveillance Solutions

FIG. 1 Infection Surveillance Solutions (ISS) Market: Research Methodology
FIG. 2 ISS Market Segmentation
FIG. 3 Global ISS Market, by Product, 2017 (US$ Mn)
FIG. 4 Global ISS Market, by Type, 2017 (US$ Mn)
FIG. 5 Global ISS Market, by End-Use, 2017 (US$ Mn)
FIG. 6 Global ISS Market, by Geography, 2017 (US$ Mn)
FIG. 7 Attractive Investment Proposition: by Geography, 2017
FIG. 8 Competitive Analysis: Global ISS Market, by Key Players, 2017
FIG. 9 Global Services Market for Infection Surveillance Solutions, 2016 – 2026 (US$ Mn)
FIG. 10 Global Software Market for Infection Surveillance Solutions, 2016 – 2026 (US$ Mn)
FIG. 11 Global Urinary Tract Infection Market for Infection Surveillance Solutions, 2016 – 2026 (US$ Mn)
FIG. 12 Global Surgical Site Infection Market for Infection Surveillance Solutions, 2016 – 2026 (US$ Mn)
FIG. 13 Global Blood Stream Infection Market for Infection Surveillance Solutions, 2016 – 2026 (US$ Mn)
FIG. 14 Global Other Infections Market for Surveillance Solutions, 2016 – 2026 (US$ Mn)
FIG. 15 Global Hospitals Market for Infection Surveillance Solutions, 2016 – 2026 (US$ Mn)
FIG. 16 Global Long Term Care Centers Market for Infection Surveillance Solutions, 2016 – 2026 (US$ Mn)
FIG. 17 Global Other End-Use Market for Infection Surveillance Solutions, 2016 – 2026 (US$ Mn)
FIG. 18 U.S. ISS Market, 2016 – 2026 (US$ Mn)
FIG. 19 Canada ISS Market, 2016 – 2026 (US$ Mn)
FIG. 20 U.K. ISS Market, 2016 – 2026 (US$ Mn)
FIG. 21 Germany ISS Market, 2016 – 2026 (US$ Mn)
FIG. 22 Rest of Europe ISS Market, 2016 – 2026 (US$ Mn)
FIG. 23 China ISS Market, 2016 – 2026 (US$ Mn)
FIG. 24 Japan ISS Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest of Asia Pacific ISS Market, 2016 – 2026 (US$ Mn)
FIG. 26 Brazil ISS Market, 2016 – 2026 (US$ Mn)
FIG. 27 Mexico ISS Market, 2016 – 2026 (US$ Mn)
FIG. 28 Rest of Latin America ISS Market, 2016 – 2026 (US$ Mn)
FIG. 29 GCC ISS Market, 2016 – 2026 (US$ Mn)
FIG. 30 Rest of MEA ISS Market, 2016 – 2026 (US$ Mn)

TABLE 1 Global Infection Surveillance Solutions (ISS) Market Portraiture
TABLE 2 Global ISS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 3 Global ISS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global ISS Market , by End-Use, 2016 – 2026 (US$ Mn)
TABLE 5 Global ISS Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 6 North America ISS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 7 North America ISS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 8 North America ISS Market, by End-Use, 2016 – 2026 (US$ Mn)
TABLE 9 North America ISS Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 10 Europe ISS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 11 Europe ISS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 12 Europe ISS Market, by End-Use, 2016 – 2026 (US$ Mn)
TABLE 13 Europe ISS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Asia Pacific ISS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 15 Asia Pacific ISS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 16 Asia Pacific ISS Market, by End-Use, 2016 – 2026 (US$ Mn)
TABLE 17 Asia Pacific ISS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 18 Latin America ISS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 19 Latin America ISS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 20 Latin America ISS Market, by End-Use, 2016 – 2026 (US$ Mn)
TABLE 21 Latin America ISS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 22 Middle East and Africa ISS Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 23 Middle East and Africa ISS Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 24 Middle East and Africa ISS Market, by End-Use, 2016 – 2026 (US$ Mn)
TABLE 25 Middle East and Africa ISS Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 26 Atlas Medical Software: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Becton Dickinson and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Baxter International, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Deb Group Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 Gojo Industries, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31 Hygreen, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 32 Premier, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 33 RL Solutions: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 34 Truven Health Analytics: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 35 Wolters Kluwer N.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)